|
![]() |
|||
|
||||
OverviewThe fields of pharmaceutical economics and health economics/policy are reaching a point of convergence. This is due to both the widespread availability of pharmaceutical treatments, accompanied by broader insurance coverage, and the regulation of prescription drugs in both private and government plans. This book will bridge the gap. We will explore developments in both U.S. and International setting. The system of the U.S. is characterized by a mix of private and government insurance for prescription drugs with the expansion of Medicare Part D. Most other developed countries are characterized by social insurance with either the government as a single payer such as in Canada or Australia, or a national health service as in many other European countries. Full Product DetailsAuthor: Michael Grossman , Björn Lindgren , Avi Dor , Avi DorPublisher: Emerald Publishing Limited Imprint: Emerald Group Publishing Limited Volume: 22 Dimensions: Width: 15.60cm , Height: 3.30cm , Length: 23.40cm Weight: 0.658kg ISBN: 9781849507165ISBN 10: 1849507163 Pages: 368 Publication Date: 30 March 2010 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |